1[3]Shepherd FA. Chemotherapy for non-small cell lung cancer: have we reached a new plateau? Semin Oncol,1999,26(1 Suppl 4):3-11.
2[4]Abbruzzese JL. Phase I studies with the novel nucleoside analog gemcitabine. Semin Oncol,1996,23(5 Suppl 10):25-31.
3[5]Bonomi PD, Finkelstein PM, Ruckdeschel JC, et al. Combination chemotherapy versus single agents followed by combination chemotherapy in stage Ⅳ non-small-cell lung cancer. A study of the Eastern Cooperative Oncology Group. J Clin Oncol,1989,7(11):1602-1613.
4[6]Langer CJ, Gandara DR, Calvert P, et al. Gemcitabine and carboplatin in combination: an update of phase Ⅰ and phase Ⅱ studies in non-small cell lung cancer. Semin Oncol,1999,26(1 Suppl 4):12-18.
3Soto Parra HJ,Cavina R,Antonelli G,et al.Superiority of three week vs four week schedule of cisplatin(CDDP)and gemcitabine(GEM): results of a randomized Phase Ⅱstudy[].Lung Cancer.2000
4Bavton BM.Gemcitabine:a pharmacologic and clinical overvier[].Cancer.1992
